Potts Jessica M, Getachew Betelihem, Vu Milkie, Nehl Eric, Yeager Katherine A, Berg Carla J
Jessica M. Potts, Student, Department of Behavioral Sciences and Health Education, Rollins School of Public Health, Emory University, Atlanta, GA, United States.
Betelihem Getachew, Project Coordinator, Department of Behavioral Sciences and Health Education, Rollins School of Public Health, Emory University, Atlanta, GA, United States.
Am J Health Behav. 2020 Nov 1;44(6):807-819. doi: 10.5993/AJHB.44.6.6.
In this study, we examined use of and interest in using opioids and marijuana, particularly in relation to use motives and perceived barriers to use, among people living with HIV (PLWH). We analyzed online survey data from 304 PLWH in the United States recruited via social media in Summer 2018. In this sample (M = 30.86, 40.5% male, 64.5% white), 16.1% reported current (past 30-day) use of opioids, 18.1% marijuana, and 15.8% both. Participants reported more use motives and fewer barriers to using marijuana versus opioids (p's < .001). The most frequently endorsed motive for using either/both drugs were to cope with pain and stress/anxiety. Highest-rated barriers to using either/both drugs were missing symptoms of worsening illness and addiction concerns. Regression analyses indicated that current opioid use correlated with reporting greater opioid use motives; among past-month opioid nonusers, greater interest in using opioids correlated with greater opioid use motives. Current marijuana use correlated with reporting greater marijuana use motives and greater barriers; among past-month marijuana nonusers, greater interest in using marijuana correlated with greater marijuana use motives and fewer barriers. Use motives and barriers differentially correlated with use and interest in use across drugs, thereby indicating different intervention approaches to address appropriate use.
在本研究中,我们调查了艾滋病毒感染者(PLWH)使用阿片类药物和大麻的情况以及使用意愿,特别是与使用动机和感知到的使用障碍相关的情况。我们分析了2018年夏季通过社交媒体招募的304名美国艾滋病毒感染者的在线调查数据。在这个样本中(M = 30.86,40.5%为男性,64.5%为白人),16.1%的人报告当前(过去30天)使用过阿片类药物,18.1%使用过大麻,15.8%两者都使用过。与阿片类药物相比,参与者报告的使用大麻的动机更多,使用障碍更少(p值<0.001)。使用这两种药物中任一种/两种药物最常被认可的动机是应对疼痛和压力/焦虑。使用这两种药物中任一种/两种药物的最高评级障碍是遗漏病情恶化症状和成瘾担忧。回归分析表明,当前使用阿片类药物与报告更高的阿片类药物使用动机相关;在过去一个月未使用阿片类药物的人群中,对使用阿片类药物的更大兴趣与更高的阿片类药物使用动机相关。当前使用大麻与报告更高的大麻使用动机和更多障碍相关;在过去一个月未使用大麻的人群中,对使用大麻的更大兴趣与更高的大麻使用动机和更少障碍相关。使用动机和障碍与不同药物的使用及使用意愿存在差异相关,从而表明需要采取不同的干预方法来解决合理使用问题。